title: Nanospheres delivering the EGFR TKI AG1478 promote optic nerve regeneration: the role of size for intraocular drug delivery.
abstract: Promoting nerve regeneration involves not only modulating the postinjury microenvironment but also ensuring survival of injured neurons. Sustained delivery of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) has been shown to promote the survival and regeneration of neurons, but systemic administration is associated with significant side effects. We fabricated poly(lactic-co-glycolic acid) (PLGA) microspheres and nanospheres containing the EGFR TKI 4-(3-chloroanilino)-6,7-dimethoxyquinazoline (AG1478) for intravitreal administration in a rat optic nerve crush injury model. Upon administration, less backflow from the injection site was observed when injecting nanospheres compared to microspheres. Two weeks after intravitreal delivery, we were able to detect microspheres and nanospheres in the vitreous using coumarin-6 fluorescence, but fewer microspheres were observed compared to the nanospheres. At four weeks only nanospheres could be detected. AG1478 microspheres and nanospheres promoted optic nerve regeneration at two weeks, and at four weeks evidence of regeneration was found only in the nanosphere-injected animals. This observation could be attributed to the ease of administration of the nanospheres versus the microspheres, which in turn led to an increased amount of spheres delivered to the vitreous in the nanosphere group compared to the microsphere group. These data provide evidence for use of PLGA nanospheres to deliver AG1478 intravitreally in a single administration to promote nerve regeneration.
authors: Department of Biomedical Engineering, Yale University, New Haven, Connecticut, United States.
authors: Rebecca
authors: R
authors: Robinson
authors: Stephen R
authors: SR
authors: Viviano
authors: Jason M
authors: JM
authors: Criscione
authors: Cicely A
authors: CA
authors: Williams
authors: Lin
authors: L
authors: Jun
authors: James C
authors: JC
authors: Tsai
authors: Erin B
authors: EB
authors: Lavik
references: J Neurosci. 2006 Jul 12;26(28):7532-40
references: 16837601
references: Med Clin North Am. 2007 Sep;91(5):937-62
references: 17826112
references: J Neurosci. 1992 Nov;12(11):4565-74
references: 1432110
references: Drug Deliv. 2004 Jul-Aug;11(4):255-61
references: 15371107
references: Eur J Neurosci. 1999 Sep;11(9):3236-46
references: 10510187
references: J Neurosci Res. 1998 Sep 15;53(6):697-717
references: 9753198
references: J Pharm Sci. 2007 Mar;96(3):558-68
references: 17177208
references: Brain. 2009 Nov;132(Pt 11):3102-21
references: 19783665
references: J Chromatogr B Biomed Sci Appl. 2001 Apr 15;754(1):193-9
references: 11318415
references: Vaccine. 1997 Apr-May;15(6-7):672-8
references: 9178469
references: Exp Neurol. 2008 Nov;214(1):10-24
references: 18647603
references: J Neurosci. 1998 Dec 15;18(24):10541-52
references: 9852591
references: Exp Neurol. 2001 Dec;172(2):257-72
references: 11716551
references: Science. 2005 Oct 7;310(5745):106-10
references: 16210539
references: J Microencapsul. 2010 May;27(3):263-71
references: 20055747
references: J Microencapsul. 2005 Feb;22(1):13-24
references: 16019887
references: Adv Drug Deliv Rev. 1997 Oct 13;28(1):5-24
references: 10837562
references: Dev Biol. 1984 May;103(1):62-70
references: 6325281
references: J Mater Sci Mater Med. 2009 May;20(5):1089-94
references: 19160026
references: Brain Res Bull. 1999 Aug;49(6):377-91
references: 10483914
references: Biochem Pharmacol. 2006 May 14;71(10):1422-34
references: 16522318
references: J Control Release. 2002 Oct 30;83(3):389-400
references: 12387947
references: Glia. 2005 Nov 15;52(3):209-18
references: 15968632
references: Biomaterials. 2006 Mar;27(8):1598-607
references: 16146647
references: J Ocul Pharmacol Ther. 2007 Jun;23(3):264-74
references: 17593010
references: J Comp Neurol. 1997 Apr 7;380(2):243-61
references: 9100135
references: J Neurosci. 2000 Jun 15;20(12):4615-26
references: 10844031
references: J Control Release. 2002 Oct 30;83(3):401-14
references: 12387948
references: Pharm Res. 2000 Jan;17(1):100-6
references: 10714616
references: Glia. 2000 Dec;32(3):328-37
references: 11102972
references: Invest Ophthalmol Vis Sci. 1998 Feb;39(2):391-6
references: 9477999
references: J Control Release. 2007 Oct 8;122(3):338-44
references: 17644208
references: EMBO J. 1998 Feb 2;17(3):719-31
references: 9450997
references: J Comp Neurol. 2007 Jan 10;500(2):299-310
references: 17111374
references: Neurobiol Dis. 2009 Oct;36(1):142-50
references: 19632327